// App-Quantinova.ai

948 : Risk Factors for Arterial Versus Venous Thrombosis in Polycythemia Vera: Single Center Experience in 587 Patients

Researchers

Presenter

  • Sonia Cerquozzi

Principal Investigators

  • Daniela Barraco

  • Terra L. Lasho

  • Christy Finke

  • Curtis A. Hanson

  • Rhett P. Ketterling

  • Animesh Pardanani

  • Naseema Gangat

  • Ayalew Tefferi

Medical Centers

  • Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN

  • Division of Medical Oncology, Mayo Clinic, Rochester, MN

  • Division of Hematopathology, Department of Laboratory Medicine, Mayo Clinic, Rochester, MN

  • Division of Hematopathology, Mayo Clinic, Rochester, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myeloid neoplasms

  • Polycythemia vera

  • Venous thrombosis

Biomarkers

  • Tet methylcytosine dioxygenase 2

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim